KV Pharmaceutical Hires Joseph Mahady as New Board Chairman
Joseph Mahady has been hired as the new board chairman by the KV Pharmaceutical.
Mahady has earlier worked as the as senior vice president of Wyeth LLC and president of Wyeth's Pharmaceuticals Inc., where he led the company's $20 billion global pharmaceutical business.
The company will be announcing other new board members in the coming weeks.
The St. Louis-based pharmaceutical company emerged from Chapter 11 bankruptcy in September with "significantly reduced debt" and a $375 million recapitalization.
Posted: October 2013